The present technology relates generally to medical devices, and more particularly, to insulin delivery devices with integrated continuous glucose monitors.
Ambulatory infusion pumps are relatively small, at least substantially self-contained devices that are used to introduce drugs and other infusible substances (collectively “medicament”) into users' bodies. Some infusion pumps are configured to be worn on a belt, carried in a clothing pocket, or the like. Other infusion pumps are configured to be adhered to skin in patch-like fashion. Infusion pumps are advantageous in that they may be used to, for example, subcutaneously introduce (or “infuse”) medicament on an ongoing or even continuous basis outside of a clinical environment. Infusion pumps are also advantageous in that they greatly reduce the frequency of subcutaneous access events such as needle-based shots. One example of a medicament that may be introduced by an infusion pump is a liquid formulation of insulin. Other exemplary medicaments that may be introduced by an infusion pump include, but are not limited to, drugs that treat cancers and drugs that suppress the perception of pain.
In some instances, ambulatory infusion pumps may automatically dispense medicament (e.g., insulin) based on measurements obtained by a real-time monitoring device. In the case of an insulin infusion pump, such a real-time monitoring device can take the form of a continuous glucose monitor (CGM). Examples of such CGMs include wearable devices having a sensor component that can be inserted into the user's skin to record a user's glucose levels continuously or periodically over time.
The use of an infusion pump device and a separate sensor device creates complexity for the user and requires significant space on a user's skin for implementation. Although combination devices have been proposed that integrate both an infusion pump and a CGM, such devices are generally bulky and expensive. Additionally, in combination devices the sensor component may be positioned too near to the insulin delivery cannula to obtain accurate physiological insulin readings of the user. Accordingly, there remains a need to develop improved ambulatory infusion pump devices with integrated sensors.
In one aspect, the present technology includes an integrated sensor and infusion device. The device includes a reservoir assembly including a reservoir configured to retain medicament therein. The device also includes a sensor electronics assembly configured to receive signals from a sensor. The device also includes an insertion assembly having a carrier assembly including a cannula carrier, an infusion cannula extending downwardly away from the cannula carrier, and a sensor electrode extending downwardly away from the cannula carrier at a position laterally spaced apart from the infusion cannula, where the infusion cannula is fluidically coupled to the reservoir, a trocar assembly including a trocar link, a first trocar configured to removably engage the infusion cannula, and a second trocar configured to removably engage the sensor electrode, the trocar assembly removably coupled to the carrier assembly, and a drive assembly includes a torsion spring coupled to the trocar assembly such that, when actuated, the torsion spring rotates to drive the trocar assembly and the carrier assembly axially downward to insert the first trocar, the infusion cannula, the second trocar, and the sensor electrode into a user's skin.
The device may also include a device housing in which each of the components of the device are configured to be housed prior to insertion of the first trocar, the infusion cannula, the second trocar, and the sensor electrode into the user's skin, and where the first trocar, the infusion cannula, the second trocar, and the sensor electrode extend out of the housing for insertion into the user's skin. The device may also be configured such that a first amount of rotation by the torsion spring drives the first trocar, the infusion cannula, the second trocar, and the sensor electrode into the user's skin, and where a second amount of rotation retracts the first trocar and the second trocar from the user's skin while leaving the infusion cannula and the sensor electrode in the user's skin. The torsion spring is actuated via a manual trigger mechanism, and/or may be actuated via a remote trigger mechanism. The first trocar can be configured to extend within a lumen of the infusion cannula. The sensor electrode can be configured to be removably received within a recess of the second trocar.
In some embodiments, the drive assembly further includes a scissor assembly coupled to the torsion spring via a drive wheel, the scissor assembly includes a first link coupled to the trocar link at a first region and a second link coupled to the trocar link at a second region, where the torsion spring, when actuated, is configured to rotate the drive wheel to cause, via the scissor assembly, the trocar link to move axially to drive the first trocar, the infusion cannula, the second trocar, and the sensor electrode into the user's skin. In some embodiments, the drive wheel is disposed within a housing and the drive wheel includes a pin received within a cam slot of the first link, such that rotation of the drive wheel causes the pin to slide within the cam slot and causes the first link to rotate relative to the drive wheel housing. The second link be coupled to the first link such that rotation of the first link causes opposite rotation of the second link. The drive assembly, when actuated, may move the scissor assembly from an unfired position in which the infusion cannula and sensor electrode are disposed within a housing of the device to an inserted position in which the infusion cannula and sensor electrode extend beyond the housing of the device. In some embodiments, in the unfired position, the first link and second link assume an expanded state in which they extend along non-parallel axes, and where, in the inserted position, the first link and the second link assume a collapsed state in which they extend more nearly parallel to one another.
In some embodiments, the drive assembly further includes a first drive wheel coupled to the torsion spring and a second drive wheel mated with the first drive wheel such that rotation of the first drive wheel causes rotation of the second drive wheel. The first drive wheel can include a first pin and the second drive wheel can include a second pin, each of the first pin and the second pin extending into a cam slot of the trocar link such that rotation of the first drive wheel and the second drive wheel causes the trocar link to move axially. Axial movement of the trocar link in the downward direction may cause axial movement of the carrier assembly in the downward direction. Rotation of the first drive wheel in a first direction may cause rotation of the second drive wheel in a second, opposite direction. The device may also include where the cannula carrier includes a first cam track configured to releasably receive the first pin therein and a second cam track configured to releasably receive the second pin therein. The device may also be configured such that the first and second pins engage the first and second cam tracks, respectively, when the trocar assembly and the carrier assembly are each in a downwardly inserted position, and where the first and second pins disengage from the first and second cam tracks when the trocar assembly is retracted upward with respect to the carrier assembly.
In another aspect, an integrated sensor and infusion device includes a torsion spring, a drive wheel coupled to the torsion spring, a scissor assembly coupled to the drive wheel, the scissor assembly includes a first link and a second link, a slide having first and second trocars coupled thereto, the slide coupled to the first link at a first region and coupled to the second link at a second region, an infusion cannula removably coupled to the first trocar, and a sensor electrode removably coupled to the second trocar, where the torsion spring, when actuated, is configured to rotate the drive wheel to cause, via the scissor assembly, the slide to move axially to drive the first trocar, the infusion cannula, the second trocar, and the sensor electrode into a user's skin.
In some embodiments, each of the components of the device are configured to be housed within a device housing prior to insertion of the first trocar, the infusion cannula, the second trocar, and the sensor electrode into the user's skin, and where the first trocar, the infusion cannula, the second trocar, and the sensor electrode extend out of the housing for insertion into the user's skin. In some embodiments, a first amount of rotation by the torsion spring drives the first trocar, the infusion cannula, the second trocar, and the sensor electrode into the user's skin, and where a second amount of rotation retracts the first trocar and the second trocar from the user's skin while leaving the infusion cannula and the sensor electrode in the user's skin. In some embodiments, the torsion spring is actuated via a manual trigger mechanism. In some embodiments, the torsion spring is actuated via a remote trigger mechanism. In some embodiments, the first trocar is configured to extend within a lumen of the infusion cannula. In some embodiments, the sensor electrode is configured to be removably received within a recess of the second trocar.
In some embodiments, the drive wheel is disposed within a drive wheel housing and the drive wheel includes a pin received within a cam slot of the first link, such that rotation of the drive wheel causes the pin to slide within the cam slot and causes the first link to rotate relative to the drive wheel housing. In some embodiments, the second link is coupled to the first link such that rotation of the first link causes opposite rotation of the second link. In some embodiments, the drive assembly, when actuated, moves the scissor assembly from an unfired position in which the infusion cannula and sensor electrode are disposed within a housing of the device to an inserted position in which the infusion cannula and sensor electrode extend beyond the housing of the device. In some embodiments, in the unfired position, the first link and second link assume an expanded state in which they extend along non-parallel axes, and where, in the inserted position, the first link and the second link assume a collapsed state in which they extend parallel to one another.
In another aspect, an integrated sensor and infusion device includes a torsion spring, a first drive wheel coupled to the torsion spring, a second drive wheel mated with the first drive wheel such that rotation of the first drive wheel causes rotation of the second drive wheel, a slide having first and second trocars coupled thereto, the slide coupled to the first drive wheel at a first region and coupled to the second drive wheel at a second region, an infusion cannula removably coupled to the first trocar, and a sensor electrode removably coupled to the second trocar, where the torsion spring, when actuated, is configured to rotate the drive wheel to cause the slide to move axially to drive the first trocar, the infusion cannula, the second trocar, and the sensor electrode into a user's skin.
In some embodiments, each of the components of the device are configured to be housed within a device housing prior to insertion of the first trocar, the infusion cannula, the second trocar, and the sensor electrode into the user's skin, and where the first trocar, the infusion cannula, the second trocar, and the sensor electrode extend out of the housing for insertion into the user's skin. In some embodiments, a first amount of rotation by the torsion spring drives the first trocar, the infusion cannula, the second trocar, and the sensor electrode into the user's skin, and where a second amount of rotation retracts the first trocar and the second trocar from the user's skin while leaving the infusion cannula and the sensor electrode in the user's skin. In some embodiments, the first amount of rotation is approximately 180 degrees, and the second amount of rotation is an additional approximately 180 degrees. In some embodiments, the torsion spring is actuated via a manual trigger mechanism. In some embodiments, the torsion spring is actuated via a remote trigger mechanism. In some embodiments, the first trocar is configured to extend within a lumen of the infusion cannula. In some embodiments, the sensor electrode is configured to be removably received within a recess of the second trocar. In some embodiments, the first drive wheel includes a first pin, and the second drive wheel includes a second pin, each of the first pin and the second pin extending into a cam slot of the trocar link such that rotation of the first drive wheel and the second drive wheel causes the trocar link to move axially. In some embodiments, axial movement of the trocar link in the downward direction causes axial movement of the carrier assembly in the downward direction. In some embodiments, rotation of the first drive wheel in a first direction causes rotation of the second drive wheel in a second, opposite direction. In some embodiments, the cannula carrier includes a first cam track configured to releasably receive the first pin therein and a second cam track configured to releasably receive the second pin therein. In some embodiments, the trocar assembly and the carrier assembly are each in a downwardly inserted position, and where the first and second pins disengage from the first and second cam tracks when the trocar assembly is retracted upward with respect to the carrier assembly.
In some embodiments, the reservoir contains medicament comprising insulin. In some embodiments, the sensor electrode includes a glucose monitor electrode. In some embodiments, the infusion cannula extends at least 3, 4, 5, 6, 7, 8, 9, 10 mm or more into the user's skin. In some embodiments, the sensor electrode extends at least 7, 8, 9, 10, 11, 12, 13, 14 mm or more into the user's skin. In some embodiments, the infusion cannula and the sensor electrode are laterally spaced apart from one another by at least 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 mm or more. In some embodiments, when positioned over the user's skin, a greatest height of the device over the user's skin is less than about 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 mm or more.
In another aspect, a method for operating an integrated sensor and infusion device, the method includes disposing a device housing over a user's skin, the device includes a drive assembly including a torsion spring, an infusion cannula fluidically coupled to a reservoir configured to hold medicament therein, and a sensor electrode. The method also includes actuating the drive assembly to rotate the torsion spring, thereby driving the infusion cannula and the sensor electrode into a user's skin. The method also includes obtaining physiological measurement(s) via the sensor electrode. The method also includes, based at least in part on the physiological measurement(s), delivering medicament into the user's body via the infusion cannula.
In some embodiments, the medicament includes insulin. In some embodiments, the physiological measurement(s) includes a blood glucose measurement. In some embodiments, the device further includes a cannula carrier coupled to the infusion cannula and the sensor electrode. In some embodiments, the device further includes a trocar assembly including a trocar link coupled to a first trocar configured to releasably engage the infusion cannula and a second trocar configured to releasably engage the sensor electrode. In some embodiments, the drive assembly further includes a scissor assembly coupled to the torsion spring via a drive wheel, and where rotation of the drive wheel causes the scissor assembly to move from an expanded configuration in which first and second links of the scissor assembly are oriented along intersecting axes to a collapsed configuration in which the first and second links of the scissor assembly are oriented substantially parallel to one another. In some embodiments, the drive assembly further includes a first drive wheel coupled to the torsion spring and a second drive wheel mated with the first drive wheel such that rotation of the first drive wheel causes rotation of the second drive wheel, and where rotation of the first drive wheel and the second drive wheel drives the infusion cannula and the sensor electrode into a user's skin.
Other technical features may be readily apparent to one skilled in the art from the following figures, descriptions, and claims.
Many aspects of the present disclosure can be better understood with reference to the following drawings. The components in the drawings are not necessarily to scale. Instead, emphasis is placed on clearly illustrating the principles of the present disclosure.
The present technology relates to wearable devices that can both deliver medicament (e.g., via infusion using a cannula inserted into a user's skin) and also monitor one or more physiological parameters (e.g., via a sensor electrode or other sensing element inserted into the user's skin). In some embodiments, the medicament delivered can include insulin, and the sensing electrode can be configured to obtain glucose measurements used to derive or infer the user's blood glucose levels. According to some examples, the device can include a housing that contains the components therein, including a reservoir, a motor to deliver medicament, and an insertion assembly to drive an infusion cannula and sensor electrode out of the housing and into the user's skin. In operation, the housing can be placed over the user's skin. After applying the device to the skin, the user activates the insertion assembly to insert the infusion cannula and the sensor electrode subcutaneously. While it is generally desirable to minimize the size of the device, there are practical limits to size reduction. For example, placing the sensor electrode and the infusion cannula too close together can reduce the accuracy of readings obtained by the sensor. As such, there may also be a minimum lateral separation between the infusion cannula and the sensor electrode. Additionally, to effectively deliver medicament and to obtain accurate sensor readings, the infusion cannula and/or the sensor electrode should be inserted to a sufficient depth beneath the surface of the user's skin. Accordingly, there may be a minimum “travel” distance required by the insertion mechanism to enable the infusion cannula and sensor electrode to penetrate the user's skin to a sufficient depth. Achieving these aspects (sufficient lateral separation and sufficient travel depth) can often lead to bulky and/or undesirably large devices.
In embodiments of the present technology, particular insertion assemblies can be used that achieve both sufficient travel depth and sufficient lateral separation without requiring undue device size (e.g., without unduly increasing the height of the device). In various examples, the drive assembly can take the form of torsion spring coupled to a trocar assembly that includes first and second trocars configured to releasably engage with an infusion cannula and a sensor electrode, respectively. When the drive assembly is actuated, the torsion spring rotates to cause the trocar assembly to fire axially downwardly, thereby driving both the infusion cannula and the sensor electrode axially downwardly and out of the device housing. By continued rotation of the torsion spring, the trocar assembly can be retracted upwardly into the device housing while the infusion cannula and sensor electrode remain in place inserted into the user's skin.
In some embodiments, the drive assembly can take the form of a scissor assembly coupled to the torsion spring. The scissor assembly can include first and second links that are aligned along intersecting axes (e.g., forming an X-shape) in an expanded, unfired state. When the torsion spring rotates to fire the trocar assembly, the first and second links move to a collapsed state in which they are more closely parallel to one another. In this process, the trocar assembly moves axially downwardly, thereby also causing the infusion cannula and sensor electrode to be moved axially downwardly and into the user's skin.
In some embodiments, the drive assembly can take the form of a dual-crank assembly in which a first drive wheel is coupled to the torsion spring, and a second drive wheel is coupled to the first drive wheel such that rotation of the torsion spring causes the first and second drive wheels to rotate in opposite directions. Each of the first and second drive wheels can include a respective pin configured to engage a cam slot of the trocar assembly, such that rotation of the drive wheels causes axial movement of the trocar assembly (e.g., in the downward direction to fire the infusion cannula and sensor electrode beyond the device housing, and in the upward direction to retract the trocar assembly back into the device housing).
To use the infusion device 100, the user (e.g., the patient) connects the disposable assembly 300 to the durable assembly 200. Unless the reservoir of the disposable assembly 300 has been sufficiently pre-loaded, the user injects a desired amount of medicament into the reservoir via a fill port disposed on a lower surface of the device 100. To adhere the device 100 to the user, an adhesive backing may be exposed on the bottom side of the device 100 and the device 100 can be applied to the skin surface. In some embodiments, the user then triggers insertion which causes both an infusion cannula and a sensor electrode to be inserted beyond the housing 302 and into the user's skin, as described in more detail below.
The durable assembly 200 may include a housing 202, which encompasses one or more electronic components, for example a buzzer or other alarm device, one or more batteries or other energy supply, a microprocessor, a coil assembly (which functions as a motor stator) including one or more Hall-effect sensors, one or more wireless transceivers, and/or any other suitable components configured to power and/or control operation of the device 100. In some embodiments, the energy supply is a rechargeable battery, such as a rechargeable lithium-ion battery, with enough power to drive the motor continuously without needing a capacitor or other additional energy storage device.
Referring specifically to
Moreover, in some embodiments the electronic components within the disposable assembly 300 can transmit data to electronic components within the durable assembly 200. For example, a continuous glucose monitor (CGM) within the disposable assembly 300 can collect low-level (e.g., millivolt) CGM signals that are conditioned (e.g., amplified, processed, digitized, etc.) within electronics of the disposable assembly 300. This pre-processed CGM data may then be wirelessly transmitted to electronic components within the durable assembly 200 for additional processing and/or for wireless transmission to external devices (e.g., smartphone, tablet, etc.). Such transmission can include, for example, Bluetooth Low Energy (BLE) or other power-efficient methods for wirelessly transmitting the data. Because the disposable assembly 300 and the durable assembly 200 are positioned so closely together, and because the transmission path is consistent and well-defined, the power required for transmission can be relatively low (as compared to systems in which a discrete CGM is positioned on an opposite side of a patient's abdomen from a patch pump device). Additionally, by providing a power source (e.g., a battery) within the disposable assembly 300, this pre-processing and data communication between the durable assembly 200 and the disposable assembly 300 can be carried out with no physical electrical connections between the two.
The disposable assembly 300, shown in more detail in
The reservoir 308 may be prefilled with a medicament. The medicament, for example, can be U-100 insulin or U-500 insulin or other concentrations of insulin to suit different user use profiles, or may be user-fillable by way of a fill port (not shown). In those cases where the reservoir 308 is filled by the user, the user may completely fill the reservoir to capacity with medicament, or the user may choose to introduce less medicament and not completely fill the reservoir. Since an unknown amount of medicament may be injected into a user-filled reservoir, a plunger-pusher zeroing procedure (or “plunger seek”) may be user-initiated or may be an automatic aspect of pump operation. A plunger seek procedure precisely determines and/or sets, before any medicament dispensing, exactly how far the pusher travels before it engages the plunger, enabling a calculation to determine the amount of medicament in the reservoir and, therefore, an estimate of time-to-empty and time for disposable assembly replacement. Additional details regarding the plunger seek procedure can be found in commonly owned U.S. application Ser. No. 17/454,600, which is hereby incorporated by reference in its entirety.
The insertion assembly 400 is configured to insert both an infusion cannula 402 and a sensor electrode 404 out of the housing 302 via a first port 406 and a second port 408, respectively. Once inserted into the user's skin, the infusion cannula 402, which is fluidically coupled to the reservoir 308, can deliver medicament (e.g., insulin) therethrough to the user. Additionally, once the sensor electrode 404 is inserted into the user's skin, the sensor electrode can detect one or more physiological parameters, such as glucose levels in the intradermal and/or subcutaneous space. As will be known to one of ordinary skill in the art, measurements of glucose obtained in intradermal and/or subcutaneous space can be used to derive or infer blood glucose levels of the user. Such physiological parameters obtained via the sensor electrode 404 can optionally be used to control delivery of medicament via the infusion cannula 402. For example, as a user's glucose rises above a predetermined threshold (as determined on readings obtained via the sensor electrode 404), the magnetic motor rotor 311 can be initiated (e.g., by the electronics in the durable assembly 200) to drive the plunger 310 an appropriate amount to dispense medicament from the reservoir 308 into the user's body via the infusion cannula 402.
As used herein with respect to a drive assembly, an “unfired state” can refer to a state in which a drive assembly has not yet moved either the trocar assembly or carrier assembly downwardly out of the housing and into a patient's skin. An “inserted state” can refer to an intermediate position in which both the trocar assembly and the carrier assembly have been moved downwardly, out of the housing, and into the patient's skin. A “fully fired state” can refer to a terminal position in which the drive assembly has retracted the trocar assembly upwardly and out of the patient's body while leaving the carrier assembly (including the sensor and cannula) extending beyond the housing and/or into the patient's body.
In various examples, the lateral distance between the infusion cannula 402 and the sensor electrode 404 can be selected to provide appropriate performance once inserted within the user's skin. If the lateral distance is too small, then the medicament provided via the infusion cannula 402 may interfere with physiological measurements obtained via the sensor electrode 404. On the other hand, having too great a lateral separation may lead to the device 100 being undesirably large and bulky. In various embodiments, the lateral separation between the infusion cannula 402 and the sensor electrode 404 can be at least about 10 mm (e.g., about 14 mm). Moreover, in some embodiments it may be desirable to insert the infusion cannula 402 and/or the sensor electrode 404 to a certain depth beneath the surface of the user's skin. If the infusion cannula 402 is not sufficiently deep, the medicament may not be effectively delivered to the user. Additionally or alternatively, if the sensor electrode 404 is not sufficiently deep, the physiological measurements may be unreliable. In various embodiments, the insertion depth (e.g., the distance from the further tip of the infusion cannula 402 and/or the sensor electrode 404 with respect to a lower surface of the housing when in the inserted state) may be at least about 6-10 mm or more. Achieving both sufficient lateral separation and sufficient insertion depth presents certain design challenges, particularly while trying to maintain a compact form factor for the device 100. Various embodiments of the drive assembly 410 disclosed herein may achieve both the desired lateral separation and the desired insertion depth for the infusion cannula 402 and the sensor electrode 404.
As described in more detail below, in operation the drive assembly 410 can be actuated to cause movement of both the trocar assembly 414 and the carrier assembly 412 downwardly from the unfired state (as shown in
The sensor electronics assembly 416 can be coupled to the carrier assembly 414 such that the two move downward together from the unfired position (
As noted above, it is the drive assembly 410 that causes the carrier assembly 412, trocar assembly 414, and sensor electronics assembly 416 to move from the unfired to the inserted position. As best seen in
As noted above, the trocar assembly 414 can be used to drive both the infusion cannula 402 and the sensor electrode 404 downwardly and beyond the housing 302 of the device 100. As best seen in
The first trocar 438 can be configured to releasably engage with the infusion cannula 402, such as by extending into a lumen of the infusion cannula 402. The second trocar 440 can be configured to releasably engage with the sensor electrode 404, such as by including a slot or recess in which the sensor electrode 404 is removably disposed. One or both of the trocars 438, 440 can have a sharp and/or pointed tip to facilitate puncturing the patient's skin. In various embodiments, the first and second trocars 438, 440 can be made of metal or other rigid material, such that the first and second trocars 438, 440 have sufficient structural integrity to be driven into the user's skin, carrying the infusion cannula 402 and sensor electrode 404 into the skin with them. Once the infusion cannula 402 and the sensor electrode 404 have been fully inserted into the user's skin, the trocar link 436 is moved upwardly (e.g., due to continued rotation of the drive wheel 422). Because the first and second trocars 438, 440 are releasably engaged with the infusion cannula 402 and the sensor electrode 404, respectively, the infusion cannula 402 and the sensor electrode 404 remain in place within the user's skin (e.g., in the inserted position as shown in
As described previously, the carrier assembly 412 can be coupled to the sensor electronics assembly 416.
The first link 464 can be joined to the second link 466 via a bearing 478 that mates with a corresponding aperture 480 in the second link 464. The bearing 478 and aperture 480 can each be disposed along a central portion of the respective first link 464 and second link 466. The second link 464 can further include a pin 482 at a first end 483 configured to engage a bearing slot 484 of the drive assembly housing 415. As best seen in
As shown in
As described above, in an integrated infusion pump and sensor device, the insertion assembly can insert both an infusion cannula and a sensor electrode into a user's skin. In various embodiments, it may be desirable to maintain both sufficient lateral separation between the infusion cannula and the sensor electrode, and to provide sufficient insertion depth, without unduly increasing the overall size of the device. In addition to the scissor assembly described above with respect to
The disposable assembly 700, shown in more detail in
The insertion assembly 800 is configured to insert both an infusion cannula 802 and a sensor electrode 804 out of the housing 702 via a first port 806 and a second port 808, respectively. Once inserted into the user's skin, the infusion cannula 802, which is fluidically coupled to the reservoir 708 (e.g., through the trocar), can deliver medicament (e.g., insulin) therethrough to the user. Additionally, once the sensor electrode 804 is inserted into the user's skin, the sensor electrode 804 can detect one or more physiological parameters, such as glucose levels in the intradermal and/or subcutaneous space. As will be known to one of ordinary skill in the art, measurements of glucose obtained in intradermal and/or subcutaneous space can be used to derive or infer blood glucose levels of the user. These physiological parameters obtained via the sensor electrode 804 can optionally be used to control delivery of medicament via the infusion cannula 802. For example, as a user's glucose rise above a predetermined threshold (as determined on readings obtained via the sensor electrode 804), a magnetic motor can be initiated to drive the plunger 710 an appropriate amount to dispense medicament from the reservoir 708 into the user's body via the infusion cannula 802.
In various examples, the lateral distance between the infusion cannula 802 and the sensor electrode 804 can be selected to provide appropriate performance once inserted within the user's skin. In various embodiments, the lateral separation between the infusion cannula 802 and the sensor electrode 804 can be at least about 10 mm or more (e.g., about 14 mm). Moreover, in some embodiments it may be desirable to insert the infusion cannula 802 and/or the sensor electrode 804 to a certain depth beneath the surface of the user's skin. In various embodiments, the insertion depth (e.g., the distance from the further tip of the infusion cannula 802 and/or the sensor electrode 804 with respect to a lower surface of the housing when in the inserted state) may be at least about 6-10 mm or more.
As described in more detail below, in operation the drive assembly 810 is actuated to cause movement of both the trocar assembly 814 and the carrier assembly 812 downwardly from the unfired state to urge the carrier assembly 812 to the inserted state (as shown in
The sensor electronics assembly 816 can be coupled to the carrier assembly 814 such that the two move downward together from the unfired position to the inserted position. The sensor electronics assembly 816 can include one or more electronic components configured to facilitate obtaining physiological measurements via the sensor electrode 804. This can include, for example, suitable analog or digital components, a battery, circuitry, processors, transceivers, etc.
As noted above, it is the drive assembly 810 that causes the carrier assembly 812, trocar assembly 814, and sensor electronics assembly 816 to move from the unfired to the inserted position. The drive assembly 810 can include a drive assembly housing 815. As best seen in
In some embodiments, the first drive wheel 824 can take the form of a main drive gear and can be coupled to a torsion spring 828. The torsion spring 828 can comprise a helical coil having an anchor pin 830 and a first crank pin 832 that extends through an aperture 834 in the first drive wheel 824. In this configuration, rotation of the first crank pin 832 with respect to the support bracket 818 will cause rotation of the first drive wheel 824, which in turn will cause a corresponding opposite rotation of the second drive wheel 826. The second drive wheel 826 can take the form of an idle gear that is not directly coupled to a torsion spring. However, a second crank pin 836 may extend from the second drive wheel 826. As described in more detail below, rotation of the first and second drive wheels 824, 826 causes the first and second crank pins 832, 836 to move rotationally. When the first and second crank pins 832, 836 are each received within a cam slot of the trocar assembly 814, this rotational movement of the drive wheels can cause the trocar assembly 814 to move axially (e.g., upwardly and downwardly).
As noted above, the trocar assembly 814 can be used to drive both the infusion cannula 802 and the sensor electrode 804 downwardly and beyond the housing of the device. As best seen in
The first trocar 838 can be configured to releasably engage with the infusion cannula 802, such as by extending into a lumen of the infusion cannula 802. The second trocar 840 can be configured to releasably engage with the sensor electrode 804, such as by including a slot or recess in which the sensor electrode 804 is removably disposed. One or both of the trocars 838, 840 can have a sharp and/or pointed tip to facilitate puncturing the patient's skin. In various embodiments, the first and second trocars 838, 840 can be made of metal or other rigid material, such that the first and second trocars 838, 840 have sufficient structural integrity to be driven into the user's skin, carrying the infusion cannula 802 and sensor electrode 804 into the skin with them. Once the infusion cannula 802 and the sensor electrode 804 have been fully inserted into the user's skin, the trocar slider 837 is moved upwardly (e.g., due to continued rotation of the drive wheels 824, 826). Because the first and second trocars 838, 840 are moveably engaged with the infusion cannula 802 and the sensor electrode 804, respectively, the infusion cannula 802 and the sensor electrode 804 remain in place within the user's skin (e.g., in the inserted position as shown in
As illustrated, the carrier assembly 812 can be coupled to the sensor electronics assembly 816. In the illustrated embodiment, the sensor electronics assembly 816 includes a printed circuit board or other substrate 863 to which a battery 862 and one or more components 864 are coupled. Such component(s) 864 can include, for example, low power wireless communication components, data processing circuitry, processing circuitry, data storage, or any other suitable components.
As described above, in an integrated infusion pump and sensor device, a disposable component can include a blood glucose sensor electrode. In various exemplary embodiments, such a device can additionally or alternatively include one or more other sensors. Data collected via such sensor(s) can be transmitted wirelessly from the disposable assembly to the durable assembly as noted previously. Among examples, the additional sensors can include hydraulic sensors to detect fluid flow throughout the assembly, plunger position sensors to detect a position of the plunger within the reservoir, mechanical sensors to detect position, orientation, strain, or other parameters of the mechanical components such as the drive assembly that moves the plunger, temperature sensors, pressure sensors, or any other suitable sensors. In various examples, the sensors can be used to evaluate pump performance (e.g., discharge pressure, bubbles, flowrate, plunger position, plunger force, leadscrew angular position) or any other desired parameters of the device.
As shown in
As best seen in
Although the devices and methods are described in the context of automatic cannula insertion and patch pumps, it should be appreciated that the techniques are equally applicable to a variety of medical devices (e.g., infusion ports) and to a variety of at least partially implantable devices (e.g., sensors). It should also be noted here that the specification describes structures and methods that are especially well-suited for the subcutaneous delivery of high concentration insulin (i.e., U-200 insulin and above) such as U-500 insulin as well as lower concentration insulin such as U-100 insulin. Nevertheless, it should be appreciated that the present inventions are applicable to a wide variety of infusion pumps and medicaments. For example, the present inventions are also applicable to medicaments such as, for example, drugs to mask pain, chemotherapy and other cancer related drugs, antibiotics, hormones, GLP-1, glucagon, various other drugs that include large molecules and proteins that may require a high level of delivery accuracy, as well as to relatively high concentration insulin (i.e., U-200 insulin and above) such as U-500 insulin, as well as lower concentration insulin, such as U-100 insulin.
The descriptions of embodiments of the technology are not intended to be exhaustive or to limit the technology to the precise form disclosed above. Where the context permits, singular or plural terms may also include the plural or singular term, respectively. Although specific embodiments of, and examples for, the technology are described above for illustrative purposes, various equivalent modifications are possible within the scope of the technology, as those skilled in the relevant art will recognize. For example, while steps are presented in a given order, alternative embodiments may perform steps in a different order. The various embodiments described herein may also be combined to provide further embodiments.
As used herein, the terms “generally,” “substantially,” “about,” and similar terms are used as terms of approximation and not as terms of degree, and are intended to account for the inherent variations in measured or calculated values that would be recognized by those of ordinary skill in the art.
Moreover, unless the word “or” is expressly limited to mean only a single item exclusive from the other items in reference to a list of two or more items, then the use of “or” in such a list is to be interpreted as including (a) any single item in the list, (b) all of the items in the list, or (c) any combination of the items in the list. Additionally, the term “comprising” is used throughout to mean including at least the recited feature(s) such that any greater number of the same feature and/or additional types of other features are not precluded. It will also be appreciated that specific embodiments have been described herein for purposes of illustration, but that various modifications may be made without deviating from the technology. Further, while advantages associated with certain embodiments of the technology have been described in the context of those embodiments, other embodiments may also exhibit such advantages, and not all embodiments need necessarily exhibit such advantages to fall within the scope of the technology. Accordingly, the disclosure and associated technology can encompass other embodiments not expressly shown or described herein.
This application claims the benefit of priority to U.S. Provisional Application No. 63/267,022, filed Jan. 21, 2022, and U.S. Provisional Application No. 63/365,544, filed May 31, 2022, which are incorporated herein by reference in their entirety.
Number | Date | Country | |
---|---|---|---|
63267022 | Jan 2022 | US | |
63365544 | May 2022 | US |